New Therapeutic Approaches and Prognostic Assays for Breast Cancer: Radiolabeled Ligands and Antibodies and Quantitative PCR

doi 10.21236/ada378605
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

New Therapeutic Approaches and Prognostic Assays for Breast Cancer: Padiolabeled Ligands and Antibodies and Quantitative PCR

1999English

Cancer Therapy With Radiolabeled and Drug/Toxin-Conjugated Antibodies

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2005English

Therapeutic Advances and New Directions for Triple-Negative Breast Cancer

Breast Care
SurgeryOncology
2017English

Animal Models for Radiolabeled Monoclonal Antibodies in Cancer Research

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1993English

New Approaches to Surgery for Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2001English

New Therapeutic Approaches in Treating Cancer

Pharmaceutical Regulatory Affairs: Open Access
2014English

Insights Into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2015English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Tinnitus—New Challenge and Therapeutic Approaches

HNO
Otorhinolaryngology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy